{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Understanding REMS & Medication Safety in Pregnancy: What Patients & Providers Need to Know","description":"Concerned about medication use during pregnancy? You\u2019re not alone.  In this episode of The MotherToBaby Podcast, host Chris Stallman, MS, CGC (genetic counselor, mom of four, teratogen information specialist) sits down with Dr. Judy C. Morrow of Harvard Medical School to break down how FDA REMS (Risk Evaluation and Mitigation Strategy) programs help reduce the risk of birth defects and protect pregnant patients. Together, they discuss: \u2714\ufe0f What REMS programs are and why they exist \u2714\ufe0f How REMS programs support safe medication use \u2714\ufe0f The role of manufacturers, prescribers, and pharmacists \u2714\ufe0f Common medications with REMS programs (including isotretinoin\/Accutane) \u2714\ufe0f Pregnancy testing requirements & pharmacy restrictions \u2714\ufe0f Why some drugs don\u2019t have REMS (even if risks exist) \u2714\ufe0f What patients should ask if they\u2019re prescribed a REMS-covered medication  Dr. Morrow shares how researchers use real-world data to identify medication-related adverse events in pregnancy, how REMS programs try to prevent exposed pregnancies, and why communication between patients, providers, and pharmacists is essential.  If you\u2019re pregnant, planning a pregnancy, breastfeeding, or support patients in these settings, this episode offers clear, practical insights to help guide informed decision-making. \ud83d\udd0e Key topics: pregnancy, REMS, FDA, teratogens, isotretinoin, Accutane, birth defects, pharmacy programs, medication safety, pregnancy data, registries \ud83c\udfa7 Listen now to learn how REMS programs help protect pregnant women and their babies. ","author_name":"The MotherToBaby Podcast","author_url":"https:\/\/mothertobaby.org\/podcast\/","html":"